Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Dahse

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Clinical Oral Investigations|November 18, 2006
High-molecular tenascin-C as an indicator of atypical cells in oral brush biopsiesO Driemel, R Dahse, A Berndt, et al.
Bone|December 14, 2004
Expression of EDA+ and EDB+ fibronectin splice variants in boneO Kilian, R Dahse, V Alt, et al.
International Journal of Molecular Medicine|June 22, 1999
Tumor suppressor gene p16 (CDKN2A) mutation status and promoter inactivation in head and neck cancerU Riese, R Dahse, W Fiedler, et al.
Archives of Dermatological Research|September 11, 1999
Analysis of the tumor suppressor gene p16(INK4A) in microdissected melanoma metastases by sequencing, and microsatellite and methylation screeningF von Eggeling, G Werner, C Theuer, et al.
Otolaryngologia Polska = the Polish Otolaryngology|August 5, 2000
Clinical implications of telomerase activity and inactivation of the tumor suppressor gene p16 (CDKN2A) in head and neck cancerS Koscielny, R Dahse, J Sonntag, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Clinical Oral Investigations|November 18, 2006
High-molecular tenascin-C as an indicator of atypical cells in oral brush biopsiesO Driemel, R Dahse, A Berndt, et al.
Bone|December 14, 2004
Expression of EDA+ and EDB+ fibronectin splice variants in boneO Kilian, R Dahse, V Alt, et al.
International Journal of Molecular Medicine|June 22, 1999
Tumor suppressor gene p16 (CDKN2A) mutation status and promoter inactivation in head and neck cancerU Riese, R Dahse, W Fiedler, et al.
Archives of Dermatological Research|September 11, 1999
Analysis of the tumor suppressor gene p16(INK4A) in microdissected melanoma metastases by sequencing, and microsatellite and methylation screeningF von Eggeling, G Werner, C Theuer, et al.
Otolaryngologia Polska = the Polish Otolaryngology|August 5, 2000
Clinical implications of telomerase activity and inactivation of the tumor suppressor gene p16 (CDKN2A) in head and neck cancerS Koscielny, R Dahse, J Sonntag, et al.
Pageof 3